Literature DB >> 22787151

Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.

Megha Maheshwari1, Ananya Samanta, Swetha K Godavarthi, Rajarshi Mukherjee, Nihar Ranjan Jana.   

Abstract

Huntington disease (HD) is a hereditary neurodegenerative disorder characterized by progressive cognitive, psychiatric, and motor symptoms. The disease is caused by abnormal expansion of CAG repeats in the gene encoding huntingtin, but how mutant huntingtin leads to early cognitive deficits in HD is poorly understood. Here, we demonstrate that the ubiquitin ligase Ube3a, which is implicated in synaptic plasticity and involved in the clearance of misfolded polyglutamine protein, is strongly recruited to the mutant huntingtin nuclear aggregates, resulting in significant loss of its functional pool in different regions of HD mouse brain. Interestingly, Arc, one of the substrates of Ube3a linked with synaptic plasticity, is also associated with nuclear aggregates, although its synaptic level is increased in the hippocampus and cortex of HD mouse brain. Different regions of HD mouse brain also exhibit decreased levels of AMPA receptors and various pre- and postsynaptic proteins, which could be due to the partial loss of function of Ube3a. Transient expression of mutant huntingtin in mouse primary cortical neurons further demonstrates recruitment of Ube3a into mutant huntingtin aggregates, increased accumulation of Arc, and decreased numbers of GluR1 puncta in the neuronal processes. Altogether, our results suggest that the loss of function of Ube3a might be associated with the synaptic abnormalities observed in HD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22787151      PMCID: PMC3436189          DOI: 10.1074/jbc.M112.371724

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice.

Authors:  Danielle A Simmons; Christopher S Rex; Linda Palmer; Vijay Pandyarajan; Vadim Fedulov; Christine M Gall; Gary Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-05       Impact factor: 11.205

2.  Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Authors:  Guerry M Peavy; Mark W Jacobson; Jody L Goldstein; Joanne M Hamilton; Amy Kane; Anthony C Gamst; Stephanie L Lessig; J C Lee; Jody Corey-Bloom
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

3.  Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a.

Authors:  Masaaki Sato; Michael P Stryker
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

4.  The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.

Authors:  Paul L Greer; Rikinari Hanayama; Brenda L Bloodgood; Alan R Mardinly; David M Lipton; Steven W Flavell; Tae-Kyung Kim; Eric C Griffith; Zachary Waldon; Rene Maehr; Hidde L Ploegh; Shoaib Chowdhury; Paul F Worley; Judith Steen; Michael E Greenberg
Journal:  Cell       Date:  2010-03-05       Impact factor: 41.582

5.  Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.

Authors:  Austen J Milnerwood; Clare M Gladding; Mahmoud A Pouladi; Alexandra M Kaufman; Rochelle M Hines; Jamie D Boyd; Rebecca W Y Ko; Oana C Vasuta; Rona K Graham; Michael R Hayden; Timothy H Murphy; Lynn A Raymond
Journal:  Neuron       Date:  2010-01-28       Impact factor: 17.173

Review 6.  Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.

Authors:  Rodrigo A Quintanilla; Gail V W Johnson
Journal:  Brain Res Bull       Date:  2009-07-19       Impact factor: 4.077

7.  Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease.

Authors:  Sudheendra N R Rao; Jaiprakash Sharma; Ranjan Maity; Nihar Ranjan Jana
Journal:  J Biol Chem       Date:  2009-11-05       Impact factor: 5.157

8.  The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein.

Authors:  Shalaka A Mulherkar; Jaiprakash Sharma; Nihar Ranjan Jana
Journal:  J Neurochem       Date:  2009-07-23       Impact factor: 5.372

9.  Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.

Authors:  Jianjun Wang; Chuan-En Wang; Adam Orr; Suzanne Tydlacka; Shi-Hua Li; Xiao-Jiang Li
Journal:  J Cell Biol       Date:  2008-03-24       Impact factor: 10.539

10.  Ube3a is required for experience-dependent maturation of the neocortex.

Authors:  Koji Yashiro; Thorfinn T Riday; Kathryn H Condon; Adam C Roberts; Danilo R Bernardo; Rohit Prakash; Richard J Weinberg; Michael D Ehlers; Benjamin D Philpot
Journal:  Nat Neurosci       Date:  2009-05-10       Impact factor: 24.884

View more
  12 in total

1.  A fine balance: Regulation of hippocampal Arc/Arg3.1 transcription, translation and degradation in a rat model of normal cognitive aging.

Authors:  Bonnie R Fletcher; Gordon S Hill; Jeffrey M Long; Michela Gallagher; Matthew L Shapiro; Peter R Rapp
Journal:  Neurobiol Learn Mem       Date:  2014-08-23       Impact factor: 2.877

Review 2.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Authors:  Rachel J Harding; Yu-Feng Tong
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

3.  UBE3A regulates the transcription of IRF, an antiviral immunity.

Authors:  Ryohei Furumai; Kota Tamada; Xiaoxi Liu; Toru Takumi
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

4.  Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease.

Authors:  Brijesh Kumar Singh; Naman Vatsa; Vinod K Nelson; Vipendra Kumar; Shashi Shekhar Kumar; Subhash C Mandal; Mahadeb Pal; Nihar Ranjan Jana
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

5.  E6AP in the brain: one protein, dual function, multiple diseases.

Authors:  Jimmy El Hokayem; Zafar Nawaz
Journal:  Mol Neurobiol       Date:  2013-10-05       Impact factor: 5.590

6.  Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.

Authors:  Kavita P Bhat; Sen Yan; Chuan-En Wang; Shihua Li; Xiao-Jiang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

7.  Grb2 is regulated by foxd3 and has roles in preventing accumulation and aggregation of mutant huntingtin.

Authors:  Shounak Baksi; Nihar R Jana; Nitai Pada Bhattacharyya; Debashis Mukhopadhyay
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

Review 8.  Ubiquitin-proteasome system involvement in Huntington's disease.

Authors:  Zaira Ortega; Jose J Lucas
Journal:  Front Mol Neurosci       Date:  2014-09-29       Impact factor: 5.639

9.  Dysregulation of core components of SCF complex in poly-glutamine disorders.

Authors:  S Bhutani; A Das; M Maheshwari; S C Lakhotia; N R Jana
Journal:  Cell Death Dis       Date:  2012-11-22       Impact factor: 8.469

Review 10.  Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective.

Authors:  François Le Guerroué; Richard J Youle
Journal:  Cell Death Differ       Date:  2020-11-18       Impact factor: 12.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.